Raf inhibitors
Raf inhibitors are a class of pharmaceutical compounds that target the Raf protein kinase family, specifically Raf-1 and B-Raf. These proteins are key components of the Ras/Raf/MEK/ERK signaling pathway, which regulates cell growth, differentiation, and survival. By inhibiting Raf kinases, these inhibitors disrupt downstream signaling cascades involved in cellular proliferation and oncogenesis. B-Raf inhibitors like vemurafenib and dabrafenib are particularly notable in cancer therapy, especially in treating melanomas harboring the BRAF V600E mutation, which constitutively activates the MAPK pathway.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:10 Page 1 of 1 1
![N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide](http://file1.lookchem.com/cas/reactions/2021/07/06/19689971.png)
![5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime](http://file1.lookchem.com/300w/substances/2022-02-14-05/5c75fbb1-ef78-499a-8650-c30a9cd71ec9.png)
![N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide](http://file1.lookchem.com/300w/substances/2022-02-14-05/dc1ef4b3-12b3-42ba-9e03-894e88a04c27.png)
